The Inc Ransom extortion gang has listed Taiwan-based specialty drugmaker Foresee Pharmaceuticals on its leak site, claiming to have walked off with 1.2 TB of files, threat trackers reported on August 18.
Ransomware.live logged the listing at 08:55 UTC with an estimated attack date of the same day and tagged the company under healthcare. The claimed haul includes drug master files, active substance master files, FDA and EMA submissions, research and development records, financial statements, and clinical study reports. The gang’s post names marketed and pipeline programs including CAMCEVI and FP-045.
GalaxyWarden, which tracks leak-site claims, flagged the incident as high severity but unverified. Foresee Pharmaceuticals has not publicly confirmed a breach, and no independent evidence of the theft has surfaced. Ransomware.live also attaches a caution note to the listing until claims are verified.
A leak of regulatory submissions and clinical documents would be a serious problem for a biopharma company, since drug master files and FDA communications are proprietary and difficult to remediate once published. The claim adds another drug developer to a year of heavy ransomware targeting of pharma firms.
Biotech and pharmaceutical security teams should treat any leak-site mention of their organization as a live incident requiring immediate credential rotation, legal review, and regulatory assessment.
